Persistent inflation and bond market volatility turned safe 40% in a 60-40 portfolio into risk. Check out three stocks to ...

By Diederik StadigUS President Donald Trump signed a new executive order on 15 April aimed at bringing US drug prices down.

Edenred's Q1 revenue growth was 7.1% on a like-for-like basis, helped by strong growth in its Beyond Food and Beyond Fuel ...

Nvidia Corp. faces challenges, with new U.S. licensing rules cutting $5.5B from quarterly sales and China's demand declining.

Explore how Intel's reliance on China revenue, manufacturing constraints, and tariff impacts could jeopardize its valuations ...

The multi-week decline of the USD/JPY from the 28 March high of 151.21 has stalled today, supported by US President Trump’s ...

Discover how the Franklin FTSE Europe outperformed global markets in early 2025, with compelling valuations and a balanced ...

Retirement savings is a critical financial goal that many individuals strive to achieve throughout their working lives. Click ...

Explore how Trump's trade war impacts the market as Fed Chair Powell resists intervention, focusing on inflation amid ...

As equities stumbled in Q1 2025, gold surged to new highs, reinforcing its role as a powerful diversifier amid shifting ...

MAGS has retraced as expected, with it remaining well supported at the established August 2024/ April 2025 bottom of $40 ...

UnitedHealth Group Incorporated dipped 20% in Q1, creating a rare buying opportunity. Click for my updated look at UNH post ...